华领医药-B(02552)下跌6.45%，报1.16元/股

金融界08-05

8月5日，华领医药-B(02552)盘中下跌6.45%，截至11:30，报1.16元/股，成交157.47万元。华领医药是一家专注于未被满足的医疗需求的创新药物研发和商业化公司，其核心产品华堂宁，也即多格列艾汀片，已于2022年9月30日获得中国国家药品监督管理局的上市批准，主要用于治疗2型糖尿病。华领医药的未来发展断点涵盖新产品上市、新市场开拓和新疾病领域三个维度，期望在全球范围内推动医药创新。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2457796612?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-05 11:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2457796612","market":"us","top_or_hot":-1,"title":"华领医药-B(02552)下跌6.45%，报1.16元/股","media":"金融界","content":"<div>\n<p>8月5日，华领医药-B(02552)盘中下跌6.45%，截至11:30，报1.16元/股，成交157.47万元。华领医药是一家专注于未被满足的医疗需求的创新药物研发和商业化公司，其核心产品华堂宁，也即多格列艾汀片，已于2022年9月30日获得中国国家药品监督管理局的上市批准，主要用于治疗2型糖尿病。华领医药的未来发展断点涵盖新产品上市、新市场开拓和新疾病领域三个维度，期望在全球范围内推动医药创新。...</p>\n\n<a href=\"https://hk.jrj.com.cn/2024/08/05113042039901.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华领医药-B(02552)下跌6.45%，报1.16元/股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华领医药-B(02552)下跌6.45%，报1.16元/股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-05 11:30 北京时间&nbsp;&nbsp;&nbsp;<a href=https://hk.jrj.com.cn/2024/08/05113042039901.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月5日，华领医药-B(02552)盘中下跌6.45%，截至11:30，报1.16元/股，成交157.47万元。华领医药是一家专注于未被满足的医疗需求的创新药物研发和商业化公司，其核心产品华堂宁，也即多格列艾汀片，已于2022年9月30日获得中国国家药品监督管理局的上市批准，主要用于治疗2型糖尿病。华领医药的未来发展断点涵盖新产品上市、新市场开拓和新疾病领域三个维度，期望在全球范围内推动医药创新。...</p>\n\n<a href=\"https://hk.jrj.com.cn/2024/08/05113042039901.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"https://hk.jrj.com.cn/2024/08/05113042039901.shtml","article_id":"2457796612","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2457796612","pubTimestamp":1722828603,"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"8月5日，华领医药-B(02552)盘中下跌6.45%，截至11:30，报1.16元/股，成交157.47万元。华领医药是一家专注于未被满足的医疗需求的创新药物研发和商业化公司，其核心产品华堂宁，也即多格列艾汀片，已于2022年9月30日获得中国国家药品监督管理局的上市批准，主要用于治疗2型糖尿病。华领医药的未来发展断点涵盖新产品上市、新市场开拓和新疾病领域三个维度，期望在全球范围内推动医药创新。截至2023年年报，华领医药-B营业总收入7661.0万元、净利润-2.11亿元。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1191":"制药","BK1574":"生物医药B类股","02552":"华领医药-B"},"translate_title":"Hua Medicine-B (02552) fell 6.45% to 1.16 yuan per share","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02552":1},"content_text":"8月5日，华领医药-B(02552)盘中下跌6.45%，截至11:30，报1.16元/股，成交157.47万元。华领医药是一家专注于未被满足的医疗需求的创新药物研发和商业化公司，其核心产品华堂宁，也即多格列艾汀片，已于2022年9月30日获得中国国家药品监督管理局的上市批准，主要用于治疗2型糖尿病。华领医药的未来发展断点涵盖新产品上市、新市场开拓和新疾病领域三个维度，期望在全球范围内推动医药创新。截至2023年年报，华领医药-B营业总收入7661.0万元、净利润-2.11亿元。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2457796612"}